|
(PQ1) GUCY2C hormone loss translates APC-Beta-catenin mutations into epithelial transformation
|
1R01CA206026-01
|
$356,850
|
WALDMAN, SCOTT
|
THOMAS JEFFERSON UNIVERSITY
|
|
(PQ1) Progression of the airway field of injury to Kras mutant lung cancer
|
1R01CA205608-01A1
|
$360,634
|
SCHEET, PAUL
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
(PQ3) Identifying Novel Pharmacologic Risk factors for Common Non-AIDS Defining Cancers in Individuals with Well-controlled HIV Infection
|
1R01CA206476-01
|
$772,521
|
CHIAO, ELIZABETH
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQA1) Aspirin and Inflammation: Mutations, Genes, Pathways and Prevention
|
4R01CA179949-04
|
$375,018
|
REID, BRIAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
(PQA1) Mechanism of Vitamin D Chemoprevention Against Colon Cancer
|
4R01CA180087-04
|
$430,436
|
LI, YAN CHUN
|
UNIVERSITY OF CHICAGO
|
|
(PQA1)The Molecular Mechanisms Underlying Effects of Aspirin on Colorectal Cancer
|
7R01CA184820-03
|
$386,650
|
DUBOIS, RAYMOND
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
(PQA3) The gut-brain axis: a novel target for treating behavioral alterations in
|
4R01CA180030-04
|
$535,999
|
DE ARAUJO, IVAN
|
JOHN B. PIERCE LABORATORY, INC.
|
|
(PQA4) Molecularly Targeted Chemoprevention for Preneoplastic Squamous (5R01 CA194617-02)
|
7R01CA194617-03
|
$194,277
|
TSAI, KENNETH
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
(PQA4) Molecularly Targeted Chemoprevention for Preneoplastic Squamous Epithelia
|
5R01CA194617-02
|
$234,646
|
TSAI, KENNETH
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
(PQC1) Accelerated biological aging and colon polyp to cancer progression
|
5R01CA194663-02
|
$401,515
|
GRADY, WILLIAM
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
15-Hydroxyprostaglandin Dehydrogenase, NSAIDs, Vitamin D, and Coloretcal Neoplasi
|
5U01CA181770-03
|
$554,959
|
LI, LI
|
CASE WESTERN RESERVE UNIVERSITY
|
|
15-LOX-1 Regulation of Resolving Generation to Modulate Colon Cancer
|
1R01CA195686-01A1
|
$366,000
|
SHUREIQI, IMAD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
15-PGDH in Cholangiocarcinogenesis
|
2R01CA102325-10A1
|
$344,269
|
WU, TONG
|
TULANE UNIVERSITY OF LOUISIANA
|
|
A chemopreventive approach of targeting breast cancer stem cells
|
5R03CA198614-02
|
$79,250
|
DIMRI, MANJARI
|
GEORGE WASHINGTON UNIVERSITY
|
|
A Narrowed Window for Targeting Metabolic Flexibility in Breast Cancer Prevention
|
4R01CA164166-04
|
$322,663
|
MACLEAN, PAUL
|
UNIVERSITY OF COLORADO DENVER
|
|
A new energy restriction mimetic that targets pancreatic cancer
|
5R21CA185276-02
|
$169,650
|
LANZA-JACOBY, SUSAN
|
THOMAS JEFFERSON UNIVERSITY
|
|
A novel combination approach for pancreatic cancer prevention
|
5R03CA181727-02
|
$79,000
|
MACKENZIE, GERARDO
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
A Novel Oral Therapeutic for Hepatocellular Carcinoma (HCC)
|
1R43CA206683-01
|
$267,105
|
GROSS, COLEMAN
|
EIGER GROUP INTERNATIONAL, INC.
|
|
A Prospective, Randomized Study to Compare Effects of Ulipristal Acetate with a Combined Oral Contraceptive on Breast Epithelial Cell Proliferation.
|
1R01CA200795-01
|
$439,302
|
WESTHOFF, CAROLYN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
A3AR agonists to prevent chemotherapy-induced painful peripheral neuropathy
|
4R01CA169519-04
|
$299,746
|
SALVEMINI, DANIELA
|
SAINT LOUIS UNIVERSITY
|
|
Aging mammary stem cells and breast cancer prevention
|
5R01CA192564-02
|
$395,434
|
SUN, LUZHE
|
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
|
|
Aldo-keto reductase family 1 member B10 AKR1B10 in pancreatic carcinogenesis
|
4R01CA164041-05
|
$320,525
|
YANG, GUANG-YU
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Anti-Migration Therapy for Prevention and Treatment of Breast Tumor
|
7R01CA160271-06
|
$308,836
|
TANAKA, TAKEMI
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
Anti-Promoting Effects of Triterpenes Alone or Combined with Other Phytochemicals
|
3R01CA164159-05S1
|
$54,438
|
DIGIOVANNI, JOHN
|
UNIVERSITY OF TEXAS, AUSTIN
|
|
Anti-Promoting Effects of Triterpenes Alone or Combined with Other Phytochemicals
|
4R01CA164159-05
|
$485,169
|
DIGIOVANNI, JOHN
|
UNIVERSITY OF TEXAS, AUSTIN
|
|
Anticarcinogenic Effect of ITCs Against Prostate Cancer
|
5R01CA101753-12
|
$346,500
|
SINGH, SHIVENDRA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Apigenin restores TSP-1 expression in UVB-irradiated keratinocytes
|
4R01CA172669-04
|
$461,702
|
VOLPERT, OLGA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Are ACF Surrogate Markers for Chemoprevention?
|
4R01CA159976-05
|
$382,490
|
ROSENBERG, DANIEL
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
Aspirin and Cancer Prevention in Lynch Syndrome: From Cell to Population Data
|
5U01CA187956-03
|
$555,997
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
Aspirin Metabolomics in Colorectal Cancer Chemoprevention
|
5R01CA188038-02
|
$363,446
|
BARRY, ELIZABETH
|
DARTMOUTH COLLEGE
|
|
Assessment of Breast Cancer Risk with High Spectral and Spatial Resolution MRI
|
4R01CA167785-04
|
$488,977
|
KARCZMAR, GREGORY
|
UNIVERSITY OF CHICAGO
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,193,520
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Barrett's Esophagus: Predictors of Progression
|
5P01CA091955-13
|
$1,315,113
|
REID, BRIAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S1
|
$118,016
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S2
|
$170,897
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S3
|
$118,875
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S4
|
$499,947
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S5
|
$134,220
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-10
|
$3,253,119
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Beneficial effects of Honokiol against liver cancer
|
5R21CA185943-02
|
$179,403
|
SAXENA, NEERAJ
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Bid-mediated killing of oncogenic stem cells in chemoprevention
|
4R01CA172136-04
|
$319,550
|
ZHANG, LIN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Biobehavioral Cancer Control and Prevention Training Grant
|
2T32CA092408-16
|
$504,006
|
THOMPSON, BETI
|
UNIVERSITY OF WASHINGTON
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$791,464
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Bisphosphonate use and Lung Cancer Incidence and Mortality in Elderly Women
|
5R03CA184327-02
|
$73,000
|
TAO, MENGHUA
|
UNIVERSITY OF NORTH TEXAS HLTH SCI CTR
|
|
Bitter Melon Component and Colon Cancer Prevention
|
5R01CA190291-03
|
$544,710
|
ANANT, SHRIKANT
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
Breast Cancer Prevention by Ayurvedic Medicine Constituents
|
5R01CA142604-07
|
$346,500
|
SINGH, SHIVENDRA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Breast Cancer Prevention by Dietary Phytochemicals
|
4R01CA129347-10
|
$282,328
|
SINGH, SHIVENDRA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Breast imaging studies in women at high genetic risk of breast cancer
|
ZIA CP010145-07040
|
$31,798
|
Loud, Jennifer
|
DCEG (NCI)
|
|
Calcium and Colorectal Cancer: Gene-Environment Interactions and Molecular Pathways
|
5K07CA188126-02
|
$144,000
|
ZHANG, XUEHONG
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-41S1
|
$120,000
|
DEPINHO, RONALD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|